Lingli Wang
Fengsong Nie3
Yang Chong- 1Department of Clinical Nutrition, The Affiliated Hospital of Yangzhou University, Yangzhou University, Jiangsu, China
- 2Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, China
- 3Department of General Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou University, Jiangsu, China
A Correction on
Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations
by Wang L, Nie F, Lu Z and Chong Y (2025) Front. Pharmacol. 16:1561112. doi: 10.3389/fphar.2025.1561112
Affiliation 1, Department of Clinical Nutrition, The Affiliated Hospital of Yangzhou University, Yangzhou University, Jiangsu, China, was omitted from the paper. This affiliation has now been added for authors Lingli Wang and Yang Chong. As such, Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, China, previously listed as affiliation 1 has been demoted to Affiliation 2. Furthermore, Department of General Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou University, Jiangsu, China, previously listed as affiliation 2 has been demoted to Affiliation 3. All the affiliation numbers have been updated accordingly in the author list.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: diabetic wound, CXCR4, CXCL12, mobilization, migration, agonist, AMD3100, responsive hydrogels
Citation: Wang L, Nie F, Lu Z and Chong Y (2025) Correction: Mechanism underlying the involvement of CXCR4/CXCL12 in diabetic wound healing and prospects for responsive hydrogel-loaded CXCR4 formulations. Front. Pharmacol. 16:1646006. doi: 10.3389/fphar.2025.1646006
Received: 12 June 2025; Accepted: 20 June 2025;
Published: 01 July 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Wang, Nie, Lu and Chong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yang Chong, MDkyMDE2QHl6dS5lZHUuY24=